Literature DB >> 26422014

Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.

Yue Zhang1, Payal Kapur2, Qing Yuan1, Yin Xi1, Ingrid Carvo3, Sabina Signoretti3, Ivan Dimitrov4, Jeffrey A Cadeddu5, Vitaly Margulis6, Naira Muradyan7, James Brugarolas8, Ananth J Madhuranthakam9, Ivan Pedrosa10.   

Abstract

UNLABELLED: Arterial spin-labeled (ASL) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) have been proposed to quantitatively assess vascularity in renal cell carcinoma (RCC). However, there are intrinsic differences between these 2 imaging methods, such as the relative contribution of vascular permeability and blood flow to signal intensity for DCE MRI. We found a correlation between ASL perfusion and the DCE-derived volume transfer constant and rate constant parameters in renal masses > 2 cm in size and these measures correlated with microvessel density in clear cell RCC.
BACKGROUND: The objective of this study was to investigate potential correlations between perfusion using arterial spin-labeled (ASL) magnetic resonance imaging (MRI) and dynamic contrast-enhanced (DCE) MRI-derived quantitative measures of vascularity in renal masses > 2 cm and to correlate these with microvessel density (MVD) in clear cell renal cell carcinoma (ccRCC). PATIENTS AND METHODS: Informed written consent was obtained from all patients before imaging in this Health Insurance Portability and Accountability Act-compliant, institutional review board-approved, prospective study. Thirty-six consecutive patients scheduled for surgery of a known renal mass > 2 cm underwent 3T ASL and DCE MRI. ASL perfusion measures (PASL) of mean, peak, and low perfusion areas within the mass were correlated to DCE-derived volume transfer constant (K(trans)), rate constant (Kep), and fractional volume of the extravascular extracellular space (Ve) in the same locations using a region of interest analysis. MRI data were correlated to MVD measures in the same tumor regions in ccRCC. Spearman correlation was used to evaluate the correlation between PASL and DCE-derived measurements, and MVD. P < .05 was considered statistically significant.
RESULTS: Histopathologic diagnosis was obtained in 36 patients (25 men; mean age 58 ± 12 years). PASL correlated with K(trans) (ρ = 0.48 and P = .0091 for the entire tumor and ρ = 0.43 and P = .03 for the high flow area, respectively) and Kep (ρ = 0.46 and P = .01 for the entire tumor and ρ = 0.52 and P = .008 for the high flow area, respectively). PASL (ρ = 0.66; P = .0002), K(trans) (ρ = 0.61; P = .001), and Kep (ρ = 0.64; P = .0006) also correlated with MVD in high and low perfusion areas in ccRCC.
CONCLUSION: PASL correlated with the DCE-derived measures of vascular permeability and flow, K(trans) and Kep, in renal masses > 2 cm in size. Both measures correlated to MVD in clear cell histology.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Arterial spin labeling; Dynamic contrast-enhanced MRI; Kidney cancers; Microvessel density

Mesh:

Substances:

Year:  2015        PMID: 26422014      PMCID: PMC4698181          DOI: 10.1016/j.clgc.2015.08.007

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  47 in total

1.  Renal-cell carcinoma--molecular pathways and therapies.

Authors:  James Brugarolas
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

Review 2.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

3.  Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression.

Authors:  M Scialpi; A Di Maggio; M Midiri; A Loperfido; G Angelelli; A Rotondo
Journal:  AJR Am J Roentgenol       Date:  2000-09       Impact factor: 3.959

4.  A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.

Authors:  Xia Li; E Brian Welch; Lori R Arlinghaus; A Bapsi Chakravarthy; Lei Xu; Jaime Farley; Mary E Loveless; Ingrid A Mayer; Mark C Kelley; Ingrid M Meszoely; Julie A Means-Powell; Vandana G Abramson; Ana M Grau; John C Gore; Thomas E Yankeelov
Journal:  Phys Med Biol       Date:  2011-08-12       Impact factor: 3.609

5.  Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.

Authors:  Olwen M Hahn; Cheng Yang; Milica Medved; Gregory Karczmar; Emily Kistner; Theodore Karrison; Elizabeth Manchen; Myrosia Mitchell; Mark J Ratain; Walter M Stadler
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

6.  Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.

Authors:  Cedric de Bazelaire; David C Alsop; Daniel George; Ivan Pedrosa; Yongyu Wang; M Dror Michaelson; Neil M Rofsky
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

7.  Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.

Authors:  Rotem S Lanzman; Phil M Robson; Maryellen R Sun; Amish D Patel; Kimiknu Mentore; Andrew A Wagner; Elizabeth M Genega; Neil M Rofsky; David C Alsop; Ivan Pedrosa
Journal:  Radiology       Date:  2012-10-09       Impact factor: 11.105

8.  Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling.

Authors:  Philip M Robson; Ananth J Madhuranthakam; Weiying Dai; Ivan Pedrosa; Neil M Rofsky; David C Alsop
Journal:  Magn Reson Med       Date:  2009-06       Impact factor: 4.668

9.  Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  M O Leach; B Morgan; P S Tofts; D L Buckley; W Huang; M A Horsfield; T L Chenevert; D J Collins; A Jackson; D Lomas; B Whitcher; L Clarke; R Plummer; I Judson; R Jones; R Alonzi; T Brunner; D M Koh; P Murphy; J C Waterton; G Parker; M J Graves; T W J Scheenen; T W Redpath; M Orton; G Karczmar; H Huisman; J Barentsz; A Padhani
Journal:  Eur Radiol       Date:  2012-05-07       Impact factor: 5.315

10.  Renal perfusion in humans: MR imaging with spin tagging of arterial water.

Authors:  D A Roberts; J A Detre; L Bolinger; E K Insko; R E Lenkinski; M J Pentecost; J S Leigh
Journal:  Radiology       Date:  1995-07       Impact factor: 11.105

View more
  19 in total

1.  Robust pCASL perfusion imaging using a 3D Cartesian acquisition with spiral profile reordering (CASPR).

Authors:  Joshua S Greer; Xinzeng Wang; Yiming Wang; Marco C Pinho; Joseph A Maldjian; Ivan Pedrosa; Ananth J Madhuranthakam
Journal:  Magn Reson Med       Date:  2019-06-23       Impact factor: 4.668

2.  Perfusion imaging of brain gliomas using arterial spin labeling: correlation with histopathological vascular density in MRI-guided biopsies.

Authors:  Di Ningning; Pang Haopeng; Dang Xuefei; Cheng Wenna; Ren Yan; Wu Jingsong; Yao Chengjun; Yao Zhenwei; Feng Xiaoyuan
Journal:  Neuroradiology       Date:  2016-12-06       Impact factor: 2.804

Review 3.  Quantitative Methods in Abdominal MRI: Perfusion Imaging.

Authors:  Ananth J Madhuranthakam; Qing Yuan; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2017-12

Review 4.  Radiomics in Kidney Cancer: MR Imaging.

Authors:  Alberto Diaz de Leon; Payal Kapur; Ivan Pedrosa
Journal:  Magn Reson Imaging Clin N Am       Date:  2019-02       Impact factor: 2.266

5.  Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience.

Authors:  Kibo Nam; John R Eisenbrey; Maria Stanczak; Anush Sridharan; Adam C Berger; Tiffany Avery; Juan P Palazzo; Flemming Forsberg
Journal:  Radiology       Date:  2017-05-03       Impact factor: 11.105

6.  Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.

Authors:  Yin Xi; Qing Yuan; Yue Zhang; Ananth J Madhuranthakam; Michael Fulkerson; Vitaly Margulis; James Brugarolas; Payal Kapur; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  Eur Radiol       Date:  2017-07-05       Impact factor: 5.315

Review 7.  Imaging of Solid Renal Masses.

Authors:  Fernando U Kay; Ivan Pedrosa
Journal:  Urol Clin North Am       Date:  2018-06-15       Impact factor: 2.241

Review 8.  Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.

Authors:  José I López; Javier C Angulo
Journal:  Curr Urol Rep       Date:  2018-01-27       Impact factor: 3.092

9.  Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity.

Authors:  Qing Yuan; Payal Kapur; Yue Zhang; Yin Xi; Ingrid Carvo; Sabina Signoretti; Ivan E Dimitrov; Jeffrey A Cadeddu; Vitaly Margulis; James Brugarolas; Ananth J Madhuranthakam; Ivan Pedrosa
Journal:  Clin Genitourin Cancer       Date:  2016-04-22       Impact factor: 2.872

10.  Development of a Patient-specific Tumor Mold Using Magnetic Resonance Imaging and 3-Dimensional Printing Technology for Targeted Tissue Procurement and Radiomics Analysis of Renal Masses.

Authors:  Durgesh Kumar Dwivedi; Yonatan Chatzinoff; Yue Zhang; Qing Yuan; Michael Fulkerson; Rajiv Chopra; James Brugarolas; Jeffrey A Cadeddu; Payal Kapur; Ivan Pedrosa
Journal:  Urology       Date:  2017-10-19       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.